Vitamin supplement to preserve insulin for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether taking a vitamin supplement called 5-MTHF (a form of folate) can help preserve remaining insulin-making ability in people with type 1 diabetes. It may slow the loss of insulin function, making diabetes easier to manage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes and are between 13 and 65 years old.
- Your diabetes diagnosis was 5 years ago or less.
- You still make some insulin on your own (verified by a blood test).
- You are able to check your blood sugar at home and keep a log.
- You are not pregnant, breastfeeding, or planning pregnancy during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral capsule called dimethyl fumarate to see if it can help preserve the body’s own insulin production in adults with type 1 diabetes. It may offer a way to slow the loss of beta cells and reduce reliance on insulin.
This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.
This trial tests an investigational gene therapy that may help people with type 1 diabetes produce some insulin on their own, potentially reducing the amount of insulin they need. It is an early-stage study, so participants will be closely monitored for safety and any changes in their diabetes control.
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
This study tests the drug dimethyl fumarate (an oral medication already used for other conditions) to see if it can help people newly diagnosed with type 1 diabetes keep making their own insulin for longer. The goal is to slow down the immune attack on the pancreas.
This trial tests a medicine called anti-thymocyte globulin (h-ATG) to see if it can help people with type 1 diabetes keep making some of their own insulin. It may slow the loss of insulin-making cells and help manage blood sugar.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.